vs
FirstEnergy(FE)とTENET HEALTHCARE CORP(THC)の財務データ比較。上の社名をクリックして会社を切り替えられます
TENET HEALTHCARE CORPの直近四半期売上が大きい($5.5B vs $3.8B、FirstEnergyの約1.5倍)。TENET HEALTHCARE CORPの純利益率が高く(11.7% vs -1.3%、差は12.9%)。FirstEnergyの前年同期比売上増加率が高い(19.6% vs 9.0%)。TENET HEALTHCARE CORPの直近四半期フリーキャッシュフローが多い($367.0M vs $-30.0M)。過去8四半期でFirstEnergyの売上複合成長率が高い(7.5% vs 1.5%)
ファーストエナジーコーポレーションは米国オハイオ州アクロンに本社を置く電力公益事業企業です。1997年にオハイオエジソン社とセンテリオールエナジー社の合併により設立され、米国中西部を中心に安定した電力供給サービスを提供しています。
テネット・ヘルスケア・コーポレーションは米国ダラスに本社を置く営利目的の多国籍医療サービス企業です。USPIをはじめとするブランド・子会社・合弁事業・提携先を通じ、65の病院と450以上の医療施設を運営するほか、Conifer Health Solutionsで医療システムなどの顧客向けに医療支援サービスを提供しています
FE vs THC — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | ||
|---|---|---|
| 売上 | $3.8B | $5.5B |
| 純利益 | $-49.0M | $644.0M |
| 粗利率 | — | — |
| 営業利益率 | -0.6% | 15.4% |
| 純利益率 | -1.3% | 11.7% |
| 売上前年比 | 19.6% | 9.0% |
| 純利益前年比 | -118.8% | 12.6% |
| EPS(希薄化後) | $-0.08 | $4.22 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $3.8B | $5.5B | ||
| Q3 25 | $4.1B | $5.3B | ||
| Q2 25 | $3.4B | $5.3B | ||
| Q1 25 | $3.8B | $5.2B | ||
| Q4 24 | $3.2B | $5.1B | ||
| Q3 24 | $3.7B | $5.1B | ||
| Q2 24 | $3.3B | $5.1B | ||
| Q1 24 | $3.3B | $5.4B |
| Q4 25 | $-49.0M | $644.0M | ||
| Q3 25 | $441.0M | $579.0M | ||
| Q2 25 | $268.0M | $522.0M | ||
| Q1 25 | $360.0M | $622.0M | ||
| Q4 24 | $261.0M | $572.0M | ||
| Q3 24 | $419.0M | $681.0M | ||
| Q2 24 | $45.0M | $477.0M | ||
| Q1 24 | $253.0M | $2.3B |
| Q4 25 | -0.6% | 15.4% | ||
| Q3 25 | 20.0% | 16.8% | ||
| Q2 25 | 19.1% | 15.6% | ||
| Q1 25 | 20.0% | 18.1% | ||
| Q4 24 | 19.3% | 16.2% | ||
| Q3 24 | 19.5% | 21.3% | ||
| Q2 24 | 12.9% | 14.9% | ||
| Q1 24 | 18.6% | 61.2% |
| Q4 25 | -1.3% | 11.7% | ||
| Q3 25 | 10.6% | 10.9% | ||
| Q2 25 | 7.9% | 9.9% | ||
| Q1 25 | 9.6% | 11.9% | ||
| Q4 24 | 8.2% | 11.3% | ||
| Q3 24 | 11.2% | 13.3% | ||
| Q2 24 | 1.4% | 9.3% | ||
| Q1 24 | 7.7% | 43.5% |
| Q4 25 | $-0.08 | $4.22 | ||
| Q3 25 | $0.76 | $3.86 | ||
| Q2 25 | $0.46 | $3.14 | ||
| Q1 25 | $0.62 | $4.27 | ||
| Q4 24 | $0.45 | $3.79 | ||
| Q3 24 | $0.73 | $4.89 | ||
| Q2 24 | $0.08 | $2.64 | ||
| Q1 24 | $0.44 | $21.38 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $57.0M | $2.9B |
| 総負債低いほど良い | $25.5B | $13.1B |
| 株主資本純資産 | $12.5B | $4.2B |
| 総資産 | $55.9B | $29.7B |
| 負債/資本比率低いほどレバレッジが低い | 2.04× | 3.10× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $57.0M | $2.9B | ||
| Q3 25 | $1.4B | $3.0B | ||
| Q2 25 | $569.0M | $2.6B | ||
| Q1 25 | $132.0M | $3.0B | ||
| Q4 24 | $111.0M | $3.0B | ||
| Q3 24 | $439.0M | $4.1B | ||
| Q2 24 | $60.0M | $2.9B | ||
| Q1 24 | $888.0M | $2.5B |
| Q4 25 | $25.5B | $13.1B | ||
| Q3 25 | $25.5B | $13.1B | ||
| Q2 25 | $23.7B | $13.1B | ||
| Q1 25 | $21.2B | $13.1B | ||
| Q4 24 | $22.5B | $13.1B | ||
| Q3 24 | $21.6B | $12.8B | ||
| Q2 24 | $20.8B | $12.8B | ||
| Q1 24 | $21.7B | $12.8B |
| Q4 25 | $12.5B | $4.2B | ||
| Q3 25 | $12.8B | $4.0B | ||
| Q2 25 | $12.9B | $3.7B | ||
| Q1 25 | $12.6B | $4.2B | ||
| Q4 24 | $12.5B | $4.2B | ||
| Q3 24 | $12.4B | $3.8B | ||
| Q2 24 | $12.5B | $3.5B | ||
| Q1 24 | $12.4B | $3.5B |
| Q4 25 | $55.9B | $29.7B | ||
| Q3 25 | $55.9B | $29.4B | ||
| Q2 25 | $54.2B | $28.7B | ||
| Q1 25 | $52.8B | $29.2B | ||
| Q4 24 | $52.0B | $28.9B | ||
| Q3 24 | $50.8B | $29.4B | ||
| Q2 24 | $51.0B | $29.3B | ||
| Q1 24 | $51.3B | $28.9B |
| Q4 25 | 2.04× | 3.10× | ||
| Q3 25 | 1.99× | 3.26× | ||
| Q2 25 | 1.85× | 3.49× | ||
| Q1 25 | 1.69× | 3.13× | ||
| Q4 24 | 1.81× | 3.14× | ||
| Q3 24 | 1.74× | 3.33× | ||
| Q2 24 | 1.67× | 3.67× | ||
| Q1 24 | 1.75× | 3.70× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $1.1B | $731.0M |
| フリーキャッシュフロー営業CF - 設備投資 | $-30.0M | $367.0M |
| FCFマージンFCF / 売上 | -0.8% | 6.6% |
| 設備投資強度設備投資 / 売上 | 30.7% | 6.6% |
| キャッシュ転換率営業CF / 純利益 | — | 1.14× |
| 直近12ヶ月FCF直近4四半期 | $-1.0B | $2.5B |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $1.1B | $731.0M | ||
| Q3 25 | $845.0M | $1.1B | ||
| Q2 25 | $1.1B | $936.0M | ||
| Q1 25 | $637.0M | $815.0M | ||
| Q4 24 | $1.0B | $-331.0M | ||
| Q3 24 | $775.0M | $1.0B | ||
| Q2 24 | $1.1B | $747.0M | ||
| Q1 24 | $-40.0M | $586.0M |
| Q4 25 | $-30.0M | $367.0M | ||
| Q3 25 | $-471.0M | $778.0M | ||
| Q2 25 | $-136.0M | $743.0M | ||
| Q1 25 | $-368.0M | $642.0M | ||
| Q4 24 | $-250.0M | $-661.0M | ||
| Q3 24 | $-229.0M | $829.0M | ||
| Q2 24 | $170.0M | $602.0M | ||
| Q1 24 | $-830.0M | $346.0M |
| Q4 25 | -0.8% | 6.6% | ||
| Q3 25 | -11.4% | 14.7% | ||
| Q2 25 | -4.0% | 14.1% | ||
| Q1 25 | -9.8% | 12.3% | ||
| Q4 24 | -7.9% | -13.0% | ||
| Q3 24 | -6.1% | 16.2% | ||
| Q2 24 | 5.2% | 11.8% | ||
| Q1 24 | -25.3% | 6.4% |
| Q4 25 | 30.7% | 6.6% | ||
| Q3 25 | 31.7% | 5.3% | ||
| Q2 25 | 36.0% | 3.7% | ||
| Q1 25 | 26.7% | 3.3% | ||
| Q4 24 | 40.7% | 6.5% | ||
| Q3 24 | 26.9% | 4.2% | ||
| Q2 24 | 28.7% | 2.8% | ||
| Q1 24 | 24.0% | 4.5% |
| Q4 25 | — | 1.14× | ||
| Q3 25 | 1.92× | 1.83× | ||
| Q2 25 | 4.04× | 1.79× | ||
| Q1 25 | 1.77× | 1.31× | ||
| Q4 24 | 4.00× | -0.58× | ||
| Q3 24 | 1.85× | 1.53× | ||
| Q2 24 | 24.71× | 1.57× | ||
| Q1 24 | -0.16× | 0.25× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
FE
| Integrated Segment | $1.4B | 37% |
| Other | $1.4B | 36% |
| Stand Alone Transmission Segment | $466.0M | 12% |
| Industrial Customers | $167.0M | 4% |
| Mid Atlantic Interstate Transmission LLC | $118.0M | 3% |
| Transmission | $105.0M | 3% |
| Transmission Segment | $68.0M | 2% |
| Tr AIL | $63.0M | 2% |
| Internal Customers | $10.0M | 0% |
| Wholesale Sales | $6.0M | 0% |
THC
| Other | $2.9B | 52% |
| Health Care Patient Service | $1.4B | 25% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $1.2B | 22% |
| Health Care Other Sources | $56.0M | 1% |